Electromed, Inc.ELMDEarnings & Financial Report
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
ELMD Q2 FY2026 Key Financial Metrics
Revenue
$18.9M
Gross Profit
$14.8M
Operating Profit
$3.6M
Net Profit
$2.8M
Gross Margin
78.4%
Operating Margin
19.2%
Net Margin
14.6%
YoY Growth
16.3%
EPS
$0.32
Electromed, Inc. Q2 FY2026 Financial Summary
Electromed, Inc. reported revenue of $18.9M (up 16.3% YoY) for Q2 FY2026, with a net profit of $2.8M (up 40.3% YoY) (14.6% margin). Cost of goods sold was $4.1M, operating expenses totaled $11.2M.
Key Financial Metrics
| Total Revenue | $18.9M |
|---|---|
| Net Profit | $2.8M |
| Gross Margin | 78.4% |
| Operating Margin | 19.2% |
| Report Period | Q2 FY2026 |
Revenue Breakdown
Electromed, Inc. Q2 FY2026 revenue of $18.9M breaks down across 2 segments, led by Homecare at $17.3M (91.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Homecare | $17.3M | 91.4% |
| Other | $1.6M | 8.6% |
Electromed, Inc. Revenue by Segment — Quarterly Trend
Electromed, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Homecare and Other) has evolved quarter over quarter.
| Segment | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 |
|---|---|---|---|---|
| Homecare | $17.3M | $14.9M | — | $14.1M |
| Other | $1.6M | $951.0K | — | $1.6M |
Electromed, Inc. Annual Revenue by Year
Electromed, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $64.0M).
Electromed, Inc. Quarterly Revenue & Net Profit History
Electromed, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $18.9M | +16.3% | $2.8M | 14.6% |
| Q1 FY2026 | $16.9M | +15.1% | $2.1M | 12.6% |
| Q4 FY2025 | $17.4M | +17.3% | $2.2M | 12.7% |
| Q3 FY2025 | $15.7M | +13.1% | $1.9M | 12.1% |
| Q2 FY2025 | $16.3M | +18.7% | $2.0M | 12.1% |
| Q1 FY2025 | $14.7M | +19.0% | $1.5M | 10.0% |
| Q4 FY2024 | $14.8M | +9.0% | $1.8M | 12.3% |
| Q3 FY2024 | $13.9M | +14.9% | $1.5M | 10.8% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.9M | $14.8M | $14.7M | $16.3M | $15.7M | $17.4M | $16.9M | $18.9M |
| YoY Growth | 14.9% | 9.0% | 19.0% | 18.7% | 13.1% | 17.3% | 15.1% | 16.3% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $48.9M | $52.2M | $48.9M | $52.3M | $52.5M | $53.8M | $53.6M | $54.9M |
| Liabilities | $6.4M | $7.7M | $7.4M | $8.7M | $8.5M | $10.6M | $8.9M | $9.5M |
| Equity | $42.5M | $44.5M | $41.5M | $43.6M | $43.9M | $43.2M | $44.7M | $45.4M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $1.4M | $4.5M | $2.3M | $3.2M | $2.1M | $3.9M | $169000 | $3.0M |